DR. COLLEEN SUSANNE DELANEY, M.D.
Medical Practice at Eastlake Ave, Seattle, WA
License number
Washington MD00039497
Category
Medical Practice
Type
Pediatric Hematology-Oncology
Address
Address
825 Eastlake Ave E, Seattle, WA 98109
Phone
(206) 288-1000
(206) 543-6420
(206) 543-6420
Personal information
See more information about COLLEEN SUSANNE DELANEY at radaris.comName
Address
Phone
6212 Madrona Dr NE, Tacoma, WA 98422
3803 S 352Nd St, Auburn, WA 98001
9229 S 244Th St, Kent, WA 98030
3516 169Th Ave NE, Bellevue, WA 98008
21219 SE 259Th St, Maple Valley, WA 98038
Professional information
Assistant Member/Assistant Professor At Fred Hutchinson Cancer Research Center
Position:
Associate Member/Associate Professor at Fred Hutchinson Cancer Research Center
Location:
Greater Seattle Area
Industry:
Medical Practice
Work:
Fred Hutchinson Cancer Research Center
- Greater Seattle Area since Jul 2011
-
Associate Member/Associate Professor
Education:
Harvard Medical School 1992 - 1996
Doctor of Medicine (M.D.), Medicine Oxford University 1989 - 1991
MSc, Social Research and Social Policy Wesleyan University 1985 - 1989
BA, Biochemistry and Molecular Biology
Doctor of Medicine (M.D.), Medicine Oxford University 1989 - 1991
MSc, Social Research and Social Policy Wesleyan University 1985 - 1989
BA, Biochemistry and Molecular Biology
Skills:
Molecular Biology, Cancer, Public Health, Clinical Research, Cell Culture, Cell Biology, Epidemiology, Western Blotting, Genetics, PCR, Clinical Trials, Biochemistry
Colleen Susanne Delaney, Seattle WA
Specialties:
Pediatric Hematologist / Oncologist
Address:
1100 Fairview Ave N, Seattle, WA 98109
825 Eastlake Ave E, Seattle, WA 98109
825 Eastlake Ave E, Seattle, WA 98109
Education:
Harvard Medical School - Doctor of Medicine
UCSF Medical Center - Residency - Pediatrics
UCSF Medical Center - Internship - Pediatrics
UCSF Medical Center - Residency - Pediatrics
UCSF Medical Center - Internship - Pediatrics
Board certifications:
American Board of Pediatrics Sub-certificate in Pediatric Hematology/Oncology (Pediatrics)
Dr. Colleen S Delaney, Seattle WA - MD (Doctor of Medicine)
Specialties:
Pediatric Hematology & Oncology
Address:
Fred Hutchinson Cncr Rsrch Ctr
1100 Fairview Ave N SUITE D3-100, Seattle 98109
(206) 667-5000 (Phone)
1100 Fairview Ave N SUITE D3-100, Seattle 98109
(206) 667-5000 (Phone)
Certifications:
Pediatric Oncology & Pediatric Hematology, 2012, Pediatrics, 1999
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Fred Hutchinson Cncr Rsrch Ctr
1100 Fairview Ave N SUITE D3-100, Seattle 98109
University of Washington Medical Center
1959 East Pacific St, Seattle 98195
1100 Fairview Ave N SUITE D3-100, Seattle 98109
University of Washington Medical Center
1959 East Pacific St, Seattle 98195
Education:
Medical School
Harvard Medical School
Graduated: 1996
Ucsf Medical Center
Fred Hutchinson Cancer Research Center/University Of Washington Medical Center
Harvard Medical School
Graduated: 1996
Ucsf Medical Center
Fred Hutchinson Cancer Research Center/University Of Washington Medical Center
Accountant At World Vision
Position:
Accountant at World Vision
Location:
Greater Seattle Area
Industry:
Nonprofit Organization Management
Work:
World Vision
-
Accountant
Co-Culture Of Placental Stem Cells And Stem Cells From A Second Source
US Patent:
8455250, Jun 4, 2013
Filed:
Dec 28, 2006
Appl. No.:
11/648824
Inventors:
Mohammad Heidaran - Chatham NJ, US
Jia-Lun Wang - Cherry Hill NJ, US
Qian Ye - Livingston NJ, US
Andrew Zeitlin - Basking Ridge NJ, US
Colleen Suzanne Delaney - Seattle WA, US
Jia-Lun Wang - Cherry Hill NJ, US
Qian Ye - Livingston NJ, US
Andrew Zeitlin - Basking Ridge NJ, US
Colleen Suzanne Delaney - Seattle WA, US
Assignee:
Anthrogenesis Corporation - Warren NJ
International Classification:
C12N 5/02
US Classification:
435373, 435325, 435366, 435372
Abstract:
The present invention relates to a combination of placental stem cells and stem or progenitor cells derived from a second source, wherein the combination shows improved engraftment as compared to placental stem cells or stem cells from a second source, alone. The combination is referred to as a combined stem cell population. The invention also provides in vitro and in vivo methods for identifying and producing combined stem cell populations, and models of engraftment. In accordance with the present invention, the placental stem cells may be combined with, e. g. , umbilical cord blood-derived stem or progenitor cells, fetal or neonatal stem cells or progenitor cells, adult stem cells or progenitor cells, hematopoietic stem cells or progenitor cells, stem or progenitor cells derived from bone marrow, etc.
Compositions And Methods For Providing Hematopoietic Function
US Patent:
2013009, Apr 18, 2013
Filed:
Apr 11, 2011
Appl. No.:
13/640298
Inventors:
Irwin D. Bernstein - Seattle WA, US
Colleen Delaney - Seattle WA, US
Colleen Delaney - Seattle WA, US
Assignee:
Fred Hutchinson Cancer Reserach Center - Seattle WA
International Classification:
A61K 35/48, G06F 19/22
US Classification:
424 937, 435372, 707758
Abstract:
The present invention relates to methods and compositions for providing hematopoietic function to human patients in need thereof, by selecting a pool of expanded human cord blood stem/progenitor cell samples for administration to the patient, wherein the samples in the pool collectively do not mismatch the patient at more than 2 of the HLA antigens or alleles typed in the patient; and administering the selected pool of expanded human cord blood stem/progenitor cell samples to the patient. Methods for obtaining the pools of expanded human cord blood stem/pro-genitor cell samples, banks of frozen pools of expanded human umbilical cord blood stem/progenitor cell samples, and methods for producing such banks are also provided herein.
Compositions And Methods For Providing Hematopoietic Function Without Hla Matching
US Patent:
2013009, Apr 18, 2013
Filed:
Apr 11, 2011
Appl. No.:
13/640297
Inventors:
Irwin D. Bernstein - Seattle WA, US
Colleen Delaney - Seattle WA, US
Colleen Delaney - Seattle WA, US
Assignee:
FRED HUTCHINSON CANCER RESEARCH CENTER - Seattle WA
International Classification:
A61K 35/48, G06F 19/00
US Classification:
424 937, 435372, 707758
Abstract:
The present invention relates to methods and compositions for providing hematopoietic function in immunodeficient human patients, by selecting an expanded human umbilical cord blood stem/progenitor cell sample without taking into account the HLA-type of the expanded human cord blood stem/progenitor sample or the HLA-type of the patient; and administering the selected expanded human cord blood stem/progenitor cell sample to the patient. Methods for obtaining the expanded human cord blood stem/progenitor cell samples, banks of frozen expanded human cord blood stem/progenitor cell samples, and methods for producing such banks are also provided herein.